228 related articles for article (PubMed ID: 21447122)
21. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
22. Advances in pathogenesis and treatment of ANCA-associated vasculitis.
Kallenberg CG
Discov Med; 2014 Oct; 18(99):195-201. PubMed ID: 25336033
[TBL] [Abstract][Full Text] [Related]
23. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
Csernok E; Reichel P; Gross WL
Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842
[TBL] [Abstract][Full Text] [Related]
24. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
25. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
27. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
28. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues.
Galperin C; Hoffman GS
Cleve Clin J Med; 1994; 61(6):416-27. PubMed ID: 7828332
[TBL] [Abstract][Full Text] [Related]
29. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
[TBL] [Abstract][Full Text] [Related]
30. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
Franssen CF; Stegeman CA; Kallenberg CG; Gans RO; De Jong PE; Hoorntje SJ; Tervaert JW
Kidney Int; 2000 Jun; 57(6):2195-206. PubMed ID: 10844589
[TBL] [Abstract][Full Text] [Related]
31. ANCA Glomerulonephritis and Vasculitis.
Jennette JC; Nachman PH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1680-1691. PubMed ID: 28842398
[TBL] [Abstract][Full Text] [Related]
32. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
33. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
35. Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis.
Bosch X
Ann Rheum Dis; 1999 Oct; 58(10):644-7. PubMed ID: 10491365
[TBL] [Abstract][Full Text] [Related]
36. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.
Kallenberg CG; Rarok A; Stegeman CA; Limburg PC
Autoimmun Rev; 2002 Feb; 1(1-2):61-6. PubMed ID: 12849060
[TBL] [Abstract][Full Text] [Related]
37. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.
Pecher AC; Henes M; Henes JC
Arch Gynecol Obstet; 2023 Aug; 308(2):379-385. PubMed ID: 36104505
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.
Chen M; Yu F; Zhang Y; Zou WZ; Zhao MH; Wang HY
Kidney Int; 2005 Nov; 68(5):2225-9. PubMed ID: 16221222
[TBL] [Abstract][Full Text] [Related]
39. Antineutrophil cytoplasmic antibodies in the classification of vasculitis.
Niles JL
Annu Rev Med; 1996; 47():303-13. PubMed ID: 8712783
[TBL] [Abstract][Full Text] [Related]
40. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]